{"component": "definition", "props": {"groups": [{"samples": [{"hash": "c4SLfoeFyAl", "uri": "/contracts/c4SLfoeFyAl#jpt", "label": "Collaboration and License Agreement (Ultragenyx Pharmaceutical Inc.)", "score": 30.5824775696, "published": true}, {"hash": "czvoWYYrKuo", "uri": "/contracts/czvoWYYrKuo#jpt", "label": "Collaboration and License Agreement (Ultragenyx Pharmaceutical Inc.)", "score": 29.1396312714, "published": true}, {"hash": "cbypN0nPxTZ", "uri": "/contracts/cbypN0nPxTZ#jpt", "label": "Collaboration and License Agreement (Dimension Therapeutics, Inc.)", "score": 26.7796039581, "published": true}], "size": 24, "snippet": "has the meaning set forth in Section 4.3.", "snippet_links": [{"key": "section-43", "type": "clause", "offset": [29, 40]}], "hash": "551cc81da46b9affe35f96da2466b855", "id": 1}, {"samples": [{"hash": "gKH6Rukubqs", "uri": "/contracts/gKH6Rukubqs#jpt", "label": "Option, License, and Collaboration Agreement", "score": 31.3408622742, "published": true}, {"hash": "eAharHezhsr", "uri": "/contracts/eAharHezhsr#jpt", "label": "Option, License, and Collaboration Agreement (Arvinas Holding Company, LLC)", "score": 29.7008895874, "published": true}, {"hash": "q4N0M9Xkus", "uri": "/contracts/q4N0M9Xkus#jpt", "label": "Option, License, and Collaboration Agreement (Arvinas Holding Company, LLC)", "score": 29.659822464, "published": true}], "size": 15, "snippet": "is defined in Section 2.2.2(a).", "snippet_links": [{"key": "defined-in-section", "type": "clause", "offset": [3, 21]}], "hash": "516520fa316b14639939a826ac3c291a", "id": 2}, {"samples": [{"hash": "bshuXmUJQK8", "uri": "/contracts/bshuXmUJQK8#jpt", "label": "License, Development and Commercialization Agreement (Fibrogen Inc)", "score": 31.8446273804, "published": true}, {"hash": "2pRa9THPkRz", "uri": "/contracts/2pRa9THPkRz#jpt", "label": "License, Development and Commercialization Agreement (Fibrogen Inc)", "score": 28.950717926, "published": true}, {"hash": "jjBdizJCLoe", "uri": "/contracts/jjBdizJCLoe#jpt", "label": "License, Development and Commercialization Agreement", "score": 26.226556778, "published": true}], "size": 14, "snippet": "has the meaning set forth in Section 2.9.", "snippet_links": [], "hash": "03347167c73b208f044c30cd967d20d1", "id": 3}, {"samples": [{"hash": "bUQDjISpoCv", "uri": "/contracts/bUQDjISpoCv#jpt", "label": "Collaboration and Commercial License Agreement (Mersana Therapeutics, Inc.)", "score": 34.3497619629, "published": true}, {"hash": "bHKMWrplZc7", "uri": "/contracts/bHKMWrplZc7#jpt", "label": "Collaboration and Commercial License Agreement", "score": 31.3408622742, "published": true}, {"hash": "df0ANPdsiJb", "uri": "/contracts/df0ANPdsiJb#jpt", "label": "Collaboration and Commercial License Agreement (Mersana Therapeutics, Inc.)", "score": 28.414100647, "published": true}], "size": 12, "snippet": "is defined in Section 2.5.3.1.", "snippet_links": [{"key": "defined-in-section", "type": "clause", "offset": [3, 21]}], "hash": "912abe3ac04c29894a0d7c5b890c9f73", "id": 4}, {"samples": [{"hash": "3f9yxkjbxJ3", "uri": "/contracts/3f9yxkjbxJ3#jpt", "label": "License and Collaboration Agreement (Zai Lab LTD)", "score": 33.1615333557, "published": true}, {"hash": "9ZQDEDVmXxD", "uri": "/contracts/9ZQDEDVmXxD#jpt", "label": "License and Collaboration Agreement (Blueprint Medicines Corp)", "score": 29.5804252625, "published": true}], "size": 7, "snippet": "has the meaning set forth in Section 3.3 (Joint Project Teams).", "snippet_links": [{"key": "section-33", "type": "clause", "offset": [29, 40]}, {"key": "joint-project-teams", "type": "clause", "offset": [42, 61]}], "hash": "36fb1185ae9bc56be5fb103ad51a462e", "id": 5}, {"samples": [{"hash": "kxyVT9TCfw9", "uri": "/contracts/kxyVT9TCfw9#jpt", "label": "Collaboration and License Agreement (Aptevo Therapeutics Inc.)", "score": 31.6173858643, "published": true}, {"hash": "iH6tgVVhJtu", "uri": "/contracts/iH6tgVVhJtu#jpt", "label": "Collaboration and License Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}, {"hash": "hlHc2DPcEBf", "uri": "/contracts/hlHc2DPcEBf#jpt", "label": "Collaboration and License Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}], "size": 6, "snippet": "shall have the meaning set forth in Section 4.8 hereof.", "snippet_links": [{"key": "section-48", "type": "clause", "offset": [36, 47]}], "hash": "8c48368e56a277f9f07de17d347119ab", "id": 6}, {"samples": [{"hash": "7WO5kpE9Hcq", "uri": "/contracts/7WO5kpE9Hcq#jpt", "label": "License Agreement (Ardelyx, Inc.)", "score": 25.4243659973, "published": true}, {"hash": "8vtllLxk5uR", "uri": "/contracts/8vtllLxk5uR#jpt", "label": "License Agreement (Ardelyx, Inc.)", "score": 25.377822876, "published": true}, {"hash": "kUJkv5yBPqp", "uri": "/contracts/kUJkv5yBPqp#jpt", "label": "License Agreement (Ardelyx, Inc.)", "score": 25.2737846375, "published": true}], "size": 6, "snippet": "shall have the meaning assigned in Section 3.1.", "snippet_links": [{"key": "section-31", "type": "definition", "offset": [35, 46]}], "hash": "0e7f4af808bacd5c19d43904f4efaaf7", "id": 7}, {"samples": [{"hash": "jtGfbEO2lVr", "uri": "/contracts/jtGfbEO2lVr#jpt", "label": "Research Collaboration and Exclusive License Agreement (Ambrx Biopharma Inc.)", "score": 32.4031486511, "published": true}, {"hash": "9dSvaAAexwp", "uri": "/contracts/9dSvaAAexwp#jpt", "label": "Research Collaboration and Exclusive License Agreement (Ambrx Biopharma Inc.)", "score": 32.2005462646, "published": true}, {"hash": "dJ3h6u3CSxf", "uri": "/contracts/dJ3h6u3CSxf#jpt", "label": "Research Collaboration and Exclusive License Agreement (Ambrx Inc)", "score": 25.3312797546, "published": true}], "size": 5, "snippet": "means the joint project team established to facilitate the Research Program, as more fully described in Section 2.4.", "snippet_links": [{"key": "joint-project-team", "type": "definition", "offset": [10, 28]}, {"key": "to-facilitate-the-research-program", "type": "clause", "offset": [41, 75]}, {"key": "section-24", "type": "definition", "offset": [104, 115]}], "hash": "7913c8728edbee2d6917a5b556d11a5e", "id": 8}, {"samples": [{"hash": "94LdbyESuNJ", "uri": "/contracts/94LdbyESuNJ#jpt", "label": "Development and Manufacturing Services Agreement (Senti Biosciences, Inc.)", "score": 36.2142372131, "published": true}, {"hash": "3VHSFTsFQ6N", "uri": "/contracts/3VHSFTsFQ6N#jpt", "label": "Framework Agreement (Senti Biosciences, Inc.)", "score": 36.2142372131, "published": true}, {"hash": "aqvhxnlpk8Y", "uri": "/contracts/aqvhxnlpk8Y#jpt", "label": "Development and Manufacturing Services Agreement (Senti Biosciences, Inc.)", "score": 34.8672142029, "published": true}], "size": 4, "snippet": "is defined in Section 4.5.1 (JPT Establishment; Composition).", "snippet_links": [{"key": "section-451", "type": "clause", "offset": [14, 27]}], "hash": "a3fb3ea1a0b2e78c908177b3f7300e75", "id": 9}, {"samples": [{"hash": "lV5k2MHNIGn", "uri": "/contracts/lV5k2MHNIGn#jpt", "label": "Collaborative Research and License Agreement (Nitromed Inc)", "score": 21.0, "published": true}, {"hash": "2wxSY3yKyMK", "uri": "/contracts/2wxSY3yKyMK#jpt", "label": "Collaborative Research and License Agreement (Archemix Corp.)", "score": 21.0, "published": true}], "size": 4, "snippet": "means the committee composed of ARCHEMIX and MERCK representatives established pursuant to Section 2.2. Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to to the Company\u2019s application requesting confidential treatment under Rule 406 of the Securities Act.", "snippet_links": [{"key": "the-committee", "type": "clause", "offset": [6, 19]}, {"key": "section-22", "type": "clause", "offset": [91, 102]}, {"key": "this-exhibit", "type": "definition", "offset": [116, 128]}, {"key": "secretary-of-the-commission", "type": "definition", "offset": [182, 209]}, {"key": "to-the-company", "type": "clause", "offset": [222, 236]}, {"key": "confidential-treatment", "type": "definition", "offset": [262, 284]}, {"key": "under-rule", "type": "clause", "offset": [285, 295]}, {"key": "the-securities-act", "type": "clause", "offset": [303, 321]}], "hash": "56287eaa4bdf455e6c6bbac5b5448b64", "id": 10}], "next_curs": "ClASSmoVc35sYXdpbnNpZGVyY29udHJhY3RzciwLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIManB0IzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"size": 145, "snippet": "has the meaning set forth in Section 4.3.", "title": "JPT", "id": "jpt", "examples": ["Alternatively, the <strong>JPT</strong> may act by written consent signed by at least [***] members designated by each Party.", "Representatives of each Party or of its Affiliates who are not members of the <strong>JPT</strong> (including, without limitation, the Patent Coordinators) may attend <strong>JPT</strong> meetings as non-voting observers without the consent of the other Party.", "Each member of the <strong>JPT</strong> shall have the opportunity to provide comments on the draft minutes.", "At each <strong>JPT</strong> meeting, (i) the presence in person of at least [***] members designated by each Party shall constitute a quorum and (ii) all members designated by each Party who are present shall have [***] on all matters before the <strong>JPT</strong> at such meeting.", "Each Party shall have the right at any time to substitute individuals, on a permanent or temporary basis, for any of its previously designated representatives to the <strong>JPT</strong>, by giving written notice to the other Party.", "Notwithstanding any other provisions of this Agreement, all decisions made and all actions taken by the <strong>JPT</strong> shall be made or taken in the best interest of the Collaboration.", "The <strong>JPT</strong> shall keep minutes of its meetings that record all decisions and all actions recommended or taken in reasonable detail.", "Each Party shall designate one of its representatives as its primary <strong>JPT</strong> contact (each, a \u201cProject Co-Leader\u201d).", "The <strong>JPT</strong> shall keep minutes of its meetings that record in writing all decisions made, action items assigned or completed and other appropriate matters.", "Each Party will bear all expenses it incurs in regard to participating in all meetings of the <strong>JPT</strong>, including all travel and living expenses."], "related": [["jrc", "JRC", "JRC"], ["jsc", "JSC", "JSC"], ["jdc", "JDC", "JDC"], ["jcc", "JCC", "JCC"], ["jmc", "JMC", "JMC"]], "related_snippets": [], "updated": "2025-10-10T05:43:31+00:00"}, "json": true, "cursor": ""}}